Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Expected Growth Rate of the Pulmonary Artery Catheter Market Based on Industry Projections?

In recent years, there has been a consistent expansion in the pulmonary artery catheter market size. It is projected to escalate from $1.2 billion in 2024 to $1.26 billion in 2025, maintaining a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth throughout the historic period encompass an increase in the elderly population, a heightened request for minimally invasive surgical procedures, the widespread presence of diabetes and hypertension, an increased frequency of cardiovascular and pulmonary diseases, as well as the rising need for advanced hemodynamic monitoring systems.

Anticipated steady growth is foreseen for the pulmonary artery catheter market in the coming years, with a prediction to reach $1.51 billion by 2029, reflecting a compound annual growth rate (CAGR) of 4.6%. Factors contributing to this projected expansion during the forecast period include the rise in health issues resulting from sedentary behaviour and poor diet, an upward trend in alcohol and tobacco use, increased funding in the health sector, a greater number of incidents of heart and lung conditions, and elevated health care spending. The upcoming trend will see a shift towards non-invasive or less invasive methods like echocardiography and reduced invasive hemodynamic tracking devices, sterile techniques, proper confirmation of catheter placement, ongoing complication surveillance, integration with sophisticated monitor systems, and customization of hemodynamic monitoring to the individual’s needs.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Pulmonary Artery Catheter Market?

The surge in heart and lung ailments is predicted to fuel the expansion of the pulmonary artery catheter market in the future. Factors such as unhealthy eating habits, inactive lifestyles, environmental and social influences, and gaps in diagnosis and treatment heavily contribute to the escalating prevalence of these diseases. Pulmonary artery catheters, which monitor the pressures within the pulmonary artery, are vital tools for diagnosing and managing heart and lung diseases. For instance, data from the Australian Institute of Health and Welfare, a national health and welfare agency, suggested in June 2024 that approximately 638,000 Australians or 2.5% of the population were suffering from chronic obstructive pulmonary disease in 2022. Furthermore, the U.S-based public health agencies, the Centers for Disease Control and Prevention, recorded in May 2024 that 702,880 heart disease-related deaths occurred in 2022, constituting 1 out of every 5 deaths. The escalating cases of heart and lung diseases thus contribute immensely to the growth of the pulmonary artery catheter market.

Request Your Free Pulmonary Artery Catheter Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20607&type=smp

What Companies Are At the Forefront of Innovation in the Pulmonary Artery Catheter Market?

Major companies operating in the pulmonary artery catheter market are:

• Cardinal Health Corp

• Medtronic Inc.

• Becton Dickinson And Company

• Philips Healthcare Corp

• Stryker Corporation

How Are Emerging Trends in Consumer Behavior Affecting the Pulmonary Artery Catheter Market?

Leading corporations in the pulmonary artery catheter sector are concentrating on creating cutting-edge endovascular catheters to improve the precision of hemodynamic monitoring, boost patient safety, and promote minimally invasive procedures used for cardiac function and pulmonary pressure evaluations. The specialized endovascular catheter is designed for precise catheterization and pulmonary artery monitoring. For example, in January 2024, Thrombolex Inc., a medical device company in the US, introduced the BASHIR .035 and BASHIR S-B endovascular catheters, aimed at treating acute pulmonary embolism (PE). These catheters, designed to be used with a 0.035 guidewire, possess a unique expandable infusion basket that facilitates targeted thrombolysis by administering thrombolytics directly into the clot. This method seeks to quickly reestablish blood flow, enhancing patient safety and reducing procedure duration.

Secure Your Global Pulmonary Artery Catheter Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/pulmonary-artery-catheter-global-market-report

Which Key Segments Define the Structure of the Pulmonary Artery Catheter Market and Their Growth Potential?

The pulmonary artery catheter market covered in this report is segmented –

1) By Product: Four Lumen Artery Catheter, Five Lumen Artery Catheter, Six Lumen Artery Catheter, Other Product Types

2) By Application: Intensive Care Units (ICUs), Non-Intensive Care Units (ICUs), Other Applications

3) By Model Of Delivery: Hospitals, Long Term Care Facilities, Other End Users

Subsegments:

1) By Four Lumen Artery Catheter: Standard Four Lumen Catheter, Thermodilution Four Lumen Catheter, Specialty Four Lumen Catheter

2) By Five Lumen Artery Catheter: Standard Five Lumen Catheter, Thermodilution Five Lumen Catheter, Specialty Five Lumen Catheter

3) By Six Lumen Artery Catheter: Standard Six Lumen Catheter, Thermodilution Six Lumen Catheter, Specialty Six Lumen Catheter

4) By Other Product Types: Introducer Sheath Catheters, Pressure Monitoring Catheters, Specialty Catheters, Disposable Pulmonary Artery Catheters

What Regions Are Propelling Growth in the Pulmonary Artery Catheter Industry?

North America was the largest region in the pulmonary artery catheter market in 2024. The regions covered in the pulmonary artery catheter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does the Definition of the Pulmonary Artery Catheter Market Include?

A pulmonary artery catheter (PAC) is a specialized catheter used to measure pressures within the heart and pulmonary artery. It provides critical information about the cardiovascular system’s function, particularly in patients with severe heart or lung conditions. PACs are commonly used in intensive care settings to monitor cardiac output, pulmonary artery pressure, and other hemodynamic parameters.

Browse Through More Similar Reports By The Business Research Company:

Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/catheters-global-market-report

Peripheral IV Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Intravascular Catheters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intravascular-catheters-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: